The healthy patient between 18 to 50 years old who have no active acne or mild to moderate bilateral facial inflammatory acne with bilateral post-acne erythema Post acne erythema
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Healthy males and females between 18 to 50 years old 2. Patients who have no active acne or mild to moderate bilateral facial inflammatory acne with bilateral post-acne erythema 3. Fitzpatrick skin Types III to V
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating woman 2. Patients who had received oral vitamin A derivatives in the past 3 months 3. Patients receiving facial laser treatments within the past 1 months 4. Patients with history of photosensitive disease 5.Patients with any medical condition that might affect acne and wound healing process 6.Patients with skin infection or history of skin cancer 7.Patients who withdrew from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Compare improvement of post-acne erythema between solid state 589 nm laser versus placebo cream (aloe vera) in the treatment of post-acne erythema at 2,4,6,8,10,12,14,18 weeks after the begin of intervention Investigator global assessment scale, Visit camera, Antera 3D skin analysis, 10 point clinical assessment score | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.patient satisfaction after treatment post acne erythema between solid state 589 nm laser versus placebo cream(aloe vera) 2.side effect from solid state 589nm laser patient record side effect at 0,2,4,6,8,10,12,14,18 weeks and pain score assessment at 0,2,4,6,8,10 weeks and patient satisfaction score at 10,12,14,18 weeks after the begin of intervention patient record side effect ,10 point pain score assessment , 10 point patient satisfaction score | — |
Countries
Thailand
Contacts
Faculty of Medicine Ramathibodi Hospital,Mahidol University